| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 12/11/2017 | Ocera Therapeutics, Inc. | OCRX | Disposition | Warrant to Purchase Common Stock | 20.2k | $0.67 | $13.5k | | 12/11/2017 |
| 12/11/2017 | Ocera Therapeutics, Inc. | OCRX | Disposition | Common Stock | 1.9M | $0.00 | $0 | | 12/11/2017 |
| 11/01/2016 | Tobira Therapeutics, Inc. | TBRA | Other | Common Stock | 285.7k | $28.35 | $8.1M | | 11/01/2016 |
| 08/03/2016 | CoLucid Pharmaceuticals, Inc. | CLCD | Sale | Common Stock | 81.1k | $8.15 | $660.9k | | 08/01/2016 |
| 08/02/2016 | CoLucid Pharmaceuticals, Inc. | CLCD | Sale | Common Stock | 19.7k | $8.71 | $171.7k | | 08/01/2016 |
| 08/01/2016 | CoLucid Pharmaceuticals, Inc. | CLCD | Sale | Common Stock | 52.2k | $8.82 | $460.5k | | 08/01/2016 |
| 04/28/2016 | CoLucid Pharmaceuticals, Inc. | CLCD | Sale | Common Stock | 149.8k | $6.96 | $1M | | 04/28/2016 |
| 03/08/2016 | Syndax Pharmaceuticals Inc | SNDX | Conversion | Common Stock | 1.7M | $0.00 | $0 | | 03/08/2016 |
| 03/08/2016 | Syndax Pharmaceuticals Inc | SNDX | Conversion | Series A-1 Preferred Stock | 1.3M | $0.00 | $0 | | 03/08/2016 |
| 03/08/2016 | Syndax Pharmaceuticals Inc | SNDX | Conversion | Series B-1 Preferred Stock | 444.5k | $0.00 | $0 | | 03/08/2016 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Common Stock | 2.2M | $0.00 | $0 | | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series A Preferred Stock | 798.2k | $0.00 | $0 | | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series B Preferred Stock | 939.3k | $0.00 | $0 | | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series C Preferred Stock | 464.8k | $0.00 | $0 | | 05/11/2015 |
| 08/05/2014 | MARINUS PHARMACEUTICALS, INC. | MRNS | Purchase | Common Stock | 419.7k | $8.00 | $3.4M | | 08/05/2014 |
| 08/05/2014 | MARINUS PHARMACEUTICALS, INC. | MRNS | Conversion | Series A Preferred Stock | 820.3k | $0.00 | $0 | | 08/05/2014 |
| 08/05/2014 | MARINUS PHARMACEUTICALS, INC. | MRNS | Conversion | Series B Preferred Stock | 657.2k | $0.00 | $0 | | 08/05/2014 |
| 08/05/2014 | MARINUS PHARMACEUTICALS, INC. | MRNS | Conversion | Series C Preferred Stock | 579.6k | $0.00 | $0 | | 08/05/2014 |
| 08/05/2014 | MARINUS PHARMACEUTICALS, INC. | MRNS | Conversion | Common Stock | 2.1M | $0.00 | $0 | | 08/05/2014 |
| 05/07/2014 | Aldeyra Therapeutics, Inc. | ALDX | Conversion | Common Stock | 21.2k | $0.00 | $0 | | 05/07/2014 |
| 05/07/2014 | Aldeyra Therapeutics, Inc. | ALDX | Conversion | Convertible Promissory Note | 0 | $8.00 | $0 | | 05/07/2014 |
| 05/01/2014 | Aldeyra Therapeutics, Inc. | ALDX | Conversion | Common Stock | 1.9M | $0.00 | $0 | | 05/01/2014 |
| 05/01/2014 | Aldeyra Therapeutics, Inc. | ALDX | Payment of Exercise | Common Stock | 39.1k | $8.00 | $312.5k | | 05/01/2014 |
| 05/01/2014 | Aldeyra Therapeutics, Inc. | ALDX | Conversion | Series A Preferred Stock | 486.3k | $0.00 | $0 | | 05/01/2014 |
| 05/01/2014 | Aldeyra Therapeutics, Inc. | ALDX | Conversion | Series B Preferred Stock | 755.3k | $0.00 | $0 | | 05/01/2014 |
| 05/01/2014 | Aldeyra Therapeutics, Inc. | ALDX | Exercise | Series B Preferred Stock Warrant (Right to Buy) | 60.6k | $5.16 | $312.6k | | 05/01/2014 |
| 03/19/2014 | CADENCE PHARMACEUTICALS INC | CADX | Disposition | Common Stock | 7.3M | $14.00 | $102.4M | | 03/19/2014 |
| 01/16/2014 | ALIMERA SCIENCES INC | ALIM | Sale | Common Stock | 204.3k | $6.56 | $1.3M | | 01/15/2014 |
| 01/15/2014 | ALIMERA SCIENCES INC | ALIM | Sale | Common Stock | 92.4k | $6.01 | $555.6k | | 01/15/2014 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series B Preferred Stock | 395k | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series C Preferred Stock | 270.6k | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock | 894.1k | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock | 225.9k | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series D Preferred Stock | 894.1k | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series E Preferred Stock | 225.9k | $0.00 | $0 | | 08/27/2013 |
|